Insight Molecular Diagnostics Inc. (IMDX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Insight Molecular Diagnostics Inc., updated every trading day.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances
Price
$3.18
+0.63% today
Market cap
$103M
Overall quality
—
Kronos AI 30-day
+38.1%
8 of 8 simulated paths end higher
Insight Molecular Diagnostics Inc. (IMDX) is a Health Care company in Biotechnology: In Vitro & In Vivo Diagnostic Substances, worth $103M. It trades at $3.18, up 0.63% today. 4 analysts' average target of $9.67 implies +204.1% from today's price. Kronos AI's 30-day forecast is +38.1% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $9.67 |
| Low – high | $8.00 – $12.00 |
| Analysts | 4 |
| Upside to average | +204.1% |
Kronos AI 30-day forecast
| Expected close | $4.37 (+38.1%) |
| Likely range | +31.5% … +57.3% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: In Vitro & In Vivo Diagnostic Substances
For information only, not investment advice. Prices updated: 2026-10-29.